Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Fischer S, Zechmeister-Koss I. Radiofrequenzablation bei benignen und malignen ver nderungen endokriner organe (schilddr se und nebenniere). [Radiofrequency ablation for the treatment of benign and malign nodules of endocrine organs (thyroid gland and adrenal gland] Vienna: Ludwig Boltzmann Institut fuer Health Technology Assessment (LBIHTA). Decision Support Dokument Nr: 56. 2012 Authors' objectives Radiofrequency ablation (RFA) is a relatively new, minimally-invasive ablation method that destroys tumors by local application of heat. This systematic review evaluates the following indications of RFA for the treatment of benign and malignant lesions of endocrine organs: benign thyroid nodules and throid cancer as well as adrenocortical adenomas and adrenal metastases. Authors' conclusions According to GRADE, the quality of evidence is very low due to the uncontrolled study design of the included case series. Overall, the available evidence is insufficient to assess the efficacy and safety of RFA compared to the respective standard therapy for the treatment of benign and malignant lesions of endocrine organs. Currently, the inclusion into the hospital benefit catalogue is not recommended. Indexing Status Subject indexing assigned by CRD MeSH Adrenal Gland Neoplasms; Catheter Ablation; Endocrine Gland Neoplasms; Thyroid Neoplasmss Country of organisation Austria English summary An English language summary is available. Address for correspondence Ludwig Boltzmann Institute fuer Health Technology Assessment (LBI-HTA), Garnisongasse 7 rechte Stiege Mezzanin (Top 20), 1090 Vienna, Austria. Tel: +43 1 236 8119 - 0 Fax: +43 1 236 8119 - 99 Email: stefan.fischer@hta.lbg.ac.at AccessionNumber 32012000774 Date abstract record published 13/10/2012 |